KLRK1 and neoplasm: Along with increased NK cell numbers, tumor-infiltrating NK cells also demonstrated an activated phenotype, as assessed by the expression of the activation molecule NKG2D and of the cytotoxic molecule TRAIL (Figure 5B), as well as the expression of the inhibitory molecule NKG2A (Figure 5B).